The Safety of Tenofovir-Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B (vol 71, pg 281, 2016)

被引：0
|
作者：
Solomon, M.
Schechter, M.
Liu, A. Y.
机构：
来源：
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2016年 / 72卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：E82 / E82
页数：1
相关论文
共 50 条
  • [41] Characterization of a Reservoir-Style Implant for Sustained Release of Tenofovir Alafenamide (TAF) for HIV Pre-Exposure Prophylaxis (PrEP)
    Johnson, Leah M.
    Krovi, Sai Archana
    Li, Linying
    Girouard, Natalie
    Demkovich, Zach R.
    Myers, Daniel
    Creelman, Ben
    van der Straten, Ariane
    PHARMACEUTICS, 2019, 11 (07)
  • [42] HIV-1 Evolution in Breakthrough Infections in a Human Trial of Oral Pre-exposure Prophylaxis With Emtricitabine and Tenofovir Disoproxil Fumarate
    Ruone, Susan
    Paxton, Lynn
    McLaurin, Tony
    Taylor, Allan
    Hanson, Debra
    Heneine, Walid
    Brooks, John T.
    Garcia-Lerma, Jose Gerardo
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2016, 72 (02) : 129 - 132
  • [43] Drug safety evaluation of oral tenofovir disoproxil fumarate-emtricitabine for pre-exposure prophylaxis for human immunodeficiency virus infection
    Trang, Tracy P.
    Dong, Betty J.
    Kojima, Noah
    Klausner, Jeffrey D.
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 (09) : 1287 - 1294
  • [44] Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study
    Molina, Jean-Michel
    Ghosn, Jade
    Assoumou, Lambert
    Delaugerre, Constance
    Algarte-Genin, Michele
    Pialoux, Gilles
    Katlama, Christine
    Slama, Laurence
    Liegeon, Geoffroy
    Beniguel, Lydie
    Ohayon, Michel
    Mouhim, Hanane
    Goldwirt, Lauriane
    Spire, Bruno
    Loze, Benedicte
    Surgers, Laure
    Pavie, Juliette
    Lourenco, Jeremy
    Ben-Mechlia, Mohamed
    Le Mestre, Soizic
    Rojas-Castro, Daniela
    Costagliola, Dominique
    LANCET HIV, 2022, 9 (08): : E554 - E562
  • [45] Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals- A systematic review
    Okwundu, C. I.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2010, 26 (10) : A94 - A94
  • [46] Real-world utilization of HIV pre-exposure prophylaxis (PREP) by cisgender and transgender individuals in the united states
    Thorburn, J.
    Paone, J.
    Kong, A.
    Bush, C.
    Patel, D.
    Carter, C.
    Das, M.
    Tao, L.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 175 - 175
  • [47] Pre-exposure prophylaxis (PrEP) for MSM in low HIV incidence places: should high risk individuals be targeted?
    Wong, Ngai Sze
    Kwan, Tsz Ho
    Tsang, Owen T. Y.
    Lee, Man Po
    Yam, Wing Cheong
    Lam, Wilson
    Leung, Wai Shing
    Chan, Jacky M. C.
    Ho, Kai Man
    Lee, Shui Shan
    SCIENTIFIC REPORTS, 2018, 8
  • [48] Pre-exposure prophylaxis (PrEP) for MSM in low HIV incidence places: should high risk individuals be targeted?
    Ngai Sze Wong
    Tsz Ho Kwan
    Owen T. Y. Tsang
    Man Po Lee
    Wing Cheong Yam
    Wilson Lam
    Wai Shing Leung
    Jacky M. C. Chan
    Kai Man Ho
    Shui Shan Lee
    Scientific Reports, 8
  • [49] Frequency of Hepatitis B Virus Resistance Mutations in Women Using Tenofovir Gel as Pre-Exposure Prophylaxis
    Baxter, Cheryl
    Ngcapu, Sinaye
    Blackard, Jason T.
    Powell, Eleanor A.
    Penton, Patricia K.
    Karim, Salim S. Abdool
    VIRUSES-BASEL, 2019, 11 (06):
  • [50] Kidney function and daily emtricitabine/tenofovir disoproxil fumarate pre-exposure prophylaxis against HIV: results from the real-life multicentric demonstrative project PrEP Brazil
    Karla Cristina Silva Petruccelli
    Djane Clarys Baía-da-Silva
    Fernando Val
    Monica Santos Valões
    Nadia Cubas-Vega
    Alexandre Vilhena Silva-Neto
    Vanderson Sampaio
    Aline Alencar
    Roberto Pecoits-Filho
    Rodrigo Carvalho Moreira
    Sandra Wagner Cardoso
    Ronaldo I. Moreira
    Iuri Costa Leite
    José Valdez Madruga
    Esper G. Kallas
    Paulo R. Alencastro
    Brenda Hoagland
    Beatriz Grinsztejn
    Valdiléa Gonçalves Veloso Santos
    Marcus Vinícius Guimarães Lacerda
    AIDS Research and Therapy, 19
12345